免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

NCT:NCT05886218 · COMPLETED

NCT编号NCT05886218
状态COMPLETED
开始日期2024-01-08
完成时间2025-08-27
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

简要摘要

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑